Semaglutide is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity. des-5-Thr-SMT is a structural analogue of semaglutide that may be produced during production or storage, characterized by the absence of threonine (Thr) at position 5. This impurity may affect the purity and biological activity of the drug, so it needs to be strictly monitored during drug development and quality control to ensure the safety and efficacy of the drug.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
His-Ala-Glu-Gly-Phe-Ser-Asp-Val-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
Single letter sequence |
HAEGETSVDVYLGQAAKELIAWLVRGRG |
Molecular formula |
C177H257N45O54S |
Molecular weight |
4,035.9 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |